HomeMost PopularReasons to Consider Adding Ingevity Stock to Your Investment Portfolio

Reasons to Consider Adding Ingevity Stock to Your Investment Portfolio

Daily Market Recaps (no fluff)

always free

Ingevity Corporation (NGVT) has seen a significant rise, with its stock jumping approximately 40% over the past three months. Expectations are high for NGVT as it focuses on restructuring its Performance Chemicals segment, making strategic acquisitions, and implementing growth strategies.

We are optimistic about the company’s future and suggest considering NGVT for your investment portfolio, as it appears ready to maintain its upward momentum.

Let’s explore the reasons why NGVT stock is an appealing investment right now.

Positive Trends in NGVT’s Earnings Estimates

Earnings projections for NGVT have improved in the past 60 days, indicating growing analyst confidence. The Zacks Consensus Estimate for the current year has risen by 15.9%.

Strong Record of Earnings Surprises

Ingevity has exceeded the Zacks Consensus Estimate in three out of the last four quarters, achieving an impressive average earnings surprise of about 95.4% during this period.

Outstanding Return on Equity (ROE)

Return on Equity (ROE) measures how efficiently a company uses its shareholders’ funds. Currently, Ingevity boasts an ROE of 24.5%, surpassing the industry standard of 16.1%.

Strategic Changes and Acquisitions Supporting Growth

Ingevity is taking deliberate steps to enhance capacity and foster long-term growth. The company is committed to organic investment and aims to maximize value from its offerings.

The upcoming repositioning of its Performance Chemicals segment aims to reduce its reliance on lower-margin markets. This strategy involves consolidating operations at the North Charleston facility, relocating oleo chemical refining to its secondary refinery, and closing the Crossett facility. These changes will streamline manufacturing and yield anticipated annual savings of $20-$25 million starting in 2025.

The benefits of this repositioning have already begun to emerge, and over the next several quarters, Ingevity will focus on executing its plans to maximize gains. Increased operational efficiency and reduced input costs are also enhancing the Performance Materials segment.

Furthermore, acquiring the Capa caprolactone business has provided Ingevity with a strong technological platform. This unit targets high-growth applications, and in July 2024, Ingevity expanded its distribution network in Europe by partnering with Ultrapolymers Group for Capa Bioplastics. The acquisition of Ozark Materials has solidified the company’s role in the paving construction sector.

Ingevity Corporation Price and Consensus

Ingevity Corporation Price and Consensus

Ingevity Corporation price-consensus-chart | Ingevity Corporation Quote

NGVT’s Zacks Ranking and Other Noteworthy Stocks

Currently, NGVT holds a Zacks Rank #2 (Buy).

Additional top-ranked stocks in the Basic Materials sector include Methanex Corporation (MEOH), Axalta Coating Systems Ltd. (AXTA), and DuPont de Nemours, Inc. (DD), all rated Zacks Rank #2. You can view the full list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Zacks Consensus Estimate for Methanex’s earnings has surged by 20.7% over the past 60 days. MEOH has outperformed consensus estimates for the past four quarters, achieving an average surprise of 101%, and its shares have increased by roughly 7% over the last year.

For Axalta Coating, the current earnings estimate stands at $2.15, reflecting a 36.9% increase from last year. Additionally, its projections have grown by 3.9% over the past 60 days, with stock gains of approximately 17% this year.

DuPont has also surpassed earnings estimates in the last four quarters, averaging a surprise of 12.9%, with its stock appreciating around 14% in the past year.

Zacks’ Top 10 Stocks for 2025

Looking to get early insights into our top 10 picks for 2025?

These selections have shown historical success.

From 2012 to November 2024, our Zacks Top 10 Stocks returned +2,112.6%, significantly outperforming the S&P 500’s +475.6%. Now, Sheraz Mian, Zacks’ Director of Research, is reviewing over 4,400 companies to find the best 10 stocks for 2025. Don’t miss the chance to invest in these top picks to be announced on January 2.

Stay Updated on New Top 10 Stocks >>

Want our latest investment recommendations? Download the report for 5 Stocks Set to Double today. Click here to access the free report.

DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report

Methanex Corporation (MEOH) : Free Stock Analysis Report

Axalta Coating Systems Ltd. (AXTA) : Free Stock Analysis Report

Ingevity Corporation (NGVT) : Free Stock Analysis Report

To read this article on Zacks.com, click here.

Zacks Investment Research

The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.

Do you want a daily market summary with no fluff?

Simple Straightforward Daily Stock Market Recaps Sent for free,every single trading day: Read Now

Explore More

Simple Straightforward Daily Stock Market Recaps

Get institutional-level analysis to take your trading to the next level, sign up for free and become apart of the community.